App developed for new glaucoma patients

City University London and Allergan have collaborated on a new tablet app to engage and educate newly diagnosed patients

allergan glaucoma app

Researchers from City University London have partnered with Allergan to create an app for patients with glaucoma.

The app, designed for use on tablet computers, aims to provide newly diagnosed patients with the information they need about the condition.

It forms part of the ‘Glaucoma in perspective’ programme, which includes a partner app aimed at healthcare professionals.

The development was led by City’s Professor David Crabb, professor of statistics and vision research, and postdoctoral researcher Dr Nicholas Smith.

Professor Crabb said: “If you have glaucoma, or someone you know has glaucoma, this app has been developed for you. By working in partnership with Allergan we hope we can help raise awareness of glaucoma and explain why people invariably have no symptoms in the early stages of the disease. We have deliberately kept the app simple to use and easy to understand. We also hope the app will help clinicians better explain the benefits of adhering to treatment.”

Allergan’s international strategic marketing director for glaucoma, Miriam Kenrick, added: “It’s been enlightening to work with Professor Crabb and his team and be part of producing something that should really make a positive difference for patients and the ophthalmology community.”

The app is available to download from iTunes.